Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathological Angiogenesis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Testing effectiveness (Phase 2)Study completedNCT03953079
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) Compared to Aflibercept in Subjects With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 56
Large-scale testing (Phase 3)Study completedNCT00429962
What this trial is testing

Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

Who this might be right for
Choroidal NeovascularizationAge-Related Macular Degeneration
University Hospital, Basel, Switzerland 40
Not applicableStudy completedNCT01880788
What this trial is testing

Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD

Who this might be right for
Age Related Macular DegenerationChoroidal NeovascularizationCentral Serous Chorioretinopathy
Sequenom, Inc. 152
Not applicableStudy completedNCT00656903
What this trial is testing

High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

Who this might be right for
Macular Degeneration
National Eye Institute (NEI) 75
Early research (Phase 1)Study completedNCT00033215
What this trial is testing

S-3304 in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Shionogi 32
Testing effectiveness (Phase 2)Study completedNCT00363714
What this trial is testing

A Dose Escalation Trial of an Intravitreal Injection of Sirna-027 in Patients With Subfoveal Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Age-Related Macular DegenerationChoroidal Neovascularization
Allergan 26
Testing effectiveness (Phase 2)Ended earlyNCT00509548
What this trial is testing

Open-Label, Pilot Study of TG100801 in Patients With Choroidal Neovascularization Due to AMD

Who this might be right for
Macular DegenerationChoroidal Neovascularization
TargeGen 7
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07346404
What this trial is testing

Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma

Who this might be right for
Renal Cell Carcinoma
Assistance Publique - Hôpitaux de Paris 50
Not applicableStudy completedNCT00512876
What this trial is testing

Effectiveness and Safety of Topical Bevacizumab (Avastin) for Treatment of Corneal Neovascularization

Who this might be right for
Corneal Neovascularization
Walter Reed Army Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00564148
What this trial is testing

Intravitreal Avastin in Proliferative Retinopathies

Who this might be right for
Retinal Neovascularization
Ophthalmological Association Edelweiss 100
Not applicableStudy completedNCT05677685
What this trial is testing

VISUPRIME® Eye Drops

Who this might be right for
Macular Degeneration, Age RelatedMyopic Choroidal NeovascularisationProliferative Diabetic Retinopathy+2 more
VISUfarma SpA 78
Not applicableUnknownNCT01148407
What this trial is testing

Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer

Who this might be right for
Cancer
University of Vermont 30
Large-scale testing (Phase 3)Study completedNCT04597632
What this trial is testing

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 248
Not applicableUnknownNCT04976244
What this trial is testing

Brolucizumab for CNV Associated With Pathologic Myopia

Who this might be right for
Pathologic Myopia
The Filatov Institute of Eye Diseases and Tissue Therapy 50
Not applicableStudy completedNCT01080898
What this trial is testing

Evaluation of Optical Coherence Tomography.

Who this might be right for
Age-Related Macular DegenerationChoroidal Vessels; Anastomosis
Assistance Publique - Hôpitaux de Paris 151
Post-approval studies (Phase 4)Study completedNCT01972789
What this trial is testing

Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)

Who this might be right for
Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
Novartis Pharmaceuticals 349
Not applicableUnknownNCT00145262
What this trial is testing

TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation

Who this might be right for
Buerger DiseaseArteriosclerosis Obliterans
Nagoya University
Not applicableStudy completedNCT01404910
What this trial is testing

Removal of Anti-Angiogenic Proteins in Preeclampsia Before Delivery

Who this might be right for
Preeclampsia
Massachusetts General Hospital 11
Large-scale testing (Phase 3)Study completedNCT00334282
What this trial is testing

Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 435
Next Page